FMR LLC 13D and 13G filings for Regeneron Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Sale | 2024-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 8,188,770 7.600% | -2,128,637 (-20.63%) | Filing |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 10,317,407 9.630% | -779,577 (-7.03%) | Filing |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 11,096,984 10.362% | 287,238 (+2.66%) | Filing |
| 2022-10-11 09:03 am Purchase | 2022-10-07 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 10,809,746 10.084% | 746,781 (+7.42%) | Filing |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 10,062,965 9.518% | -1,418,606 (-12.36%) | Filing |
| 2021-02-08 10:31 am Sale | 2021-02-05 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 11,481,571 10.949% | -723,674 (-5.93%) | Filing |